Clinical Trial Update: Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis [Phase 2]

View source ↗

Summary

Phase 2 study characterizing the use of the radiotracer 18F-fluciclovine PET to evaluate resected brain metastases and brain cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Metastases

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Brain Metastases, Brain Cancer | Phase 2 | Status: RECRUITING